1. Home
  2. SIGA vs LAB Comparison

SIGA vs LAB Comparison

Compare SIGA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$3.64

Market Cap

309.8M

Sector

Health Care

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.82

Market Cap

347.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIGA
LAB
Founded
1995
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
309.8M
347.5M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
SIGA
LAB
Price
$3.64
$0.82
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.35
AVG Volume (30 Days)
488.9K
5.8M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
13.24%
N/A
EPS Growth
N/A
61.54
EPS
N/A
0.33
Revenue
N/A
$101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$224.81
$2.63
P/E Ratio
N/A
$2.26
Revenue Growth
N/A
N/A
52 Week Low
$3.56
$0.70
52 Week High
$9.62
$1.72

Technical Indicators

Market Signals
Indicator
SIGA
LAB
Relative Strength Index (RSI) 23.13 44.97
Support Level N/A $0.79
Resistance Level $4.84 $1.02
Average True Range (ATR) 0.15 0.07
MACD -0.07 -0.01
Stochastic Oscillator 8.14 55.08

Price Performance

Historical Comparison
SIGA
LAB

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: